MDNews - Long Island

July 2015

Issue link: https://viewer.e-digitaledition.com/i/538303

Contents of this Issue

Navigation

Page 19 of 31

A TEAM OF fi ve researchers conducted a meta-analysis of six studies to examine the link between NSAID use and VTE. The studies represented 21,401 VTE events. "We found that use of NSAIDs is associated with a higher risk of developing VTE — about 80 percent higher compared with the general population," says Patompong Ungprasert, MD, Instructor of Medicine, Division of Rheumatology, Department of Medicine at Mayo Clinic. That has signifi cant clinical implications because more than 30 million people take NSAIDs in prescription or nonprescrip- tion form each day for relief from headaches, backaches and arthritis pain, and to reduce fever, according to the American Gastroenterological Association. It also reinforces concerns about serious side effects from these drugs. NSAID-related conditions such as ulcers lead to more than 100,000 hospitalizations and thousands of deaths annually across the nation. "This is the first systematic review and meta-anal- ysis of published observational studies to examine the association between NSAID use and VTE," says Narat Srivali, MD, a Fellow of Pulmonary and Critical Care Medicine at Mayo Clinic. "We used observational studies for this analysis because VTE is too rare to show up reliably in most randomized clinical trials." The research discovered no clear mechanism that was responsible for the link between NSAID use and VTE, but researchers have some ideas. "Inhibition of the COX-2 enzyme has been shown to inhibit the synthesis of prostacyclin, potent platelet activation inhibitors, while stimulating the release of thromboxane, a potent platelet aggregation facilitator, from the activated platelets," Dr. Srivali says. "The activation and aggregation of platelets might, in turn, induce a coagulation cascade and clotting." "We cannot say with certainty that NSAIDs cause the increased risk of VTE," Dr. Ungprasert says. "All we can s ay i s t he u s e of NSA IDs is associ- ated with a higher risk, as patients who take NSAIDs might h a v e u n d e r l y i n g conditions that lead to VTE." That association leads the researchers to urge caution among physicians when they administer NSAIDs to patients with VTE risk factors, such as cancer or lack of mobility. "Our study shows that a person who takes NSAIDs has a 1.8-fold increased risk of developing VTE," Dr. Ungprasert says. "It would be prudent to avoid prescribing NSAIDs to patients who have a higher baseline risk of VTE." In otherwise healthy patients with a very low baseline risk, researchers conclude that taking NSAIDs should have no significant impact. ■ to Higher Venous Thromboembolism Risk By Cathy Higgins THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) IS ASSOCIATED WITH A GREATER RISK OF VENOUS THROMBOEMBOLISM (VTE), ACCORDING TO RESEARCH IN THE JOURNAL RHEUMATOLOGY. "Physicians should be aware of this association [between NSAIDs and VTE], and NSAIDs should be prescribed with caution, especially in patients already at a higher risk for VTE." — Narat Srivali, MD, Fellow of Pulmonary and Critical Care Medicine at Mayo Clinic Research Links NSAID Use SPECIAL CLINICAL SECTION: PLASTIC SURGERY 2 0 | Long Island MD NEWS ■ M D N E W S . CO M

Articles in this issue

Archives of this issue

view archives of MDNews - Long Island - July 2015